Nino Hallén Selected Research

semaglutide

2/2021	Evaluating the Cost-Effectiveness of Once-Weekly Semaglutide 1 mg Versus Empagliflozin 25 mg for Treatment of Patients with Type 2 Diabetes in the UK Setting.
10/2020	Evaluation of the Long-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Dulaglutide and Sitagliptin in the Spanish Setting.
2/2020	The Short-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Once-Daily Sitagliptin and Once-Weekly Dulaglutide for the Treatment of Patients with Type 2 Diabetes: A Cost of Control Analysis in Spain.
2/2020	Assessing the cost-effectiveness of a once-weekly GLP-1 analogue versus an SGLT-2 inhibitor in the Spanish setting: Once-weekly semaglutide versus empagliflozin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nino Hallén Research Topics

Disease

6	Type 2 Diabetes Mellitus (MODY) 12/2020 - 06/2018
4	Diabetes Complications 10/2020 - 06/2018
3	Hypoglycemia (Reactive Hypoglycemia) 02/2020 - 06/2018
1	Diabetes Mellitus 02/2021
1	Body Weight (Weight, Body) 02/2020
1	Weight Gain 02/2020
1	Weight Loss (Weight Reduction) 02/2020
1	Myocardial Infarction 01/2019
1	Stroke (Strokes) 01/2019

Drug/Important Bio-Agent (IBA)

4	semaglutideIBA 02/2021 - 02/2020
3	insulin degludecIBA 10/2019 - 06/2018
3	Insulin Glargine (Lantus)FDA Link 10/2019 - 06/2018
2	empagliflozinIBA 02/2021 - 02/2020
2	dulaglutideIBA 10/2020 - 02/2020
2	Sitagliptin Phosphate (Januvia)FDA Link 10/2020 - 02/2020
1	Metformin (Glucophage)FDA LinkGeneric 02/2021
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 02/2020
1	Insulin (Novolin)FDA Link 10/2019

Therapy/Procedure

3	Glycemic Control 10/2020 - 02/2020
1	Ambulatory Care (Outpatient Care) 12/2020